Long-Term Efficacy and Safety With Ibrutinib in CLL Cancer Therapy Advisor 3:39 7 years ago 1 139 Далее Скачать
CLL: Long-term updates on ibrutinib and idelalisib HMP Education 25:09 6 years ago 2 194 Далее Скачать
Dr. Byrd on Ibrutinib's Impact on Treatment Landscape in CLL OncLive 1:29 8 years ago 705 Далее Скачать
Long-term outcomes and toxicities of ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:22 1 year ago 334 Далее Скачать
Abstract: Single-agent Ibrutinib 420mg Induces Durable Responses in Patients with CLL HMP Education 14:12 9 years ago 1 211 Далее Скачать
The safety and efficacy of ibrutinib for the treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:39 2 years ago 1 374 Далее Скачать
Update on BTK inhibitors for CLL: Ibrutinib pus the new kids on the block: Are they better? HMP Education 21:42 6 years ago 3 663 Далее Скачать
Big data on efficacy and toxicity levels for ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:58 7 years ago 632 Далее Скачать
First results of head-to-head acalabrutinib versus ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:52 3 years ago 1 217 Далее Скачать
Ibrutinib significantly delays disease progression and extends survival in resistant or relapsed CLL ecancer 4:22 10 years ago 87 Далее Скачать
Dr. Brander on the Safety and Efficacy of Ibrutinib/Venetoclax in CLL OncLive 2:12 5 years ago 561 Далее Скачать
Dr. Pinilla-Ibarz on Ibrutinib's Efficacy in Treating High-Risk Patients With CLL OncLive 0:55 7 years ago 374 Далее Скачать
